ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Stomach Cancer
Colorectal Cancer
Esophageal Cancer
Prostatic Cancer

Adenocarcinoma trials near Sevilla, AN, ESP:

Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients (OPTIMIZE-1)

Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Biological: CD40 agonist mitazalimab in combination with chemotherapy

Phase 1, Phase 2

Alligator Bioscience

Sevilla, Spain and 13 other locations

This study is being done to find out if zanidatamab, when given with chemotherapy plus or minus tislelizumab, is safe and works better than trastuzum...

Active, not recruiting
Gastroesophageal Adenocarcinoma
Esophageal Adenocarcinoma
Drug: Tislelizumab
Drug: Capecitabine

Phase 3

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Sevilla, Spain and 230 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: AZD0901
Drug: Docetaxel

Phase 3

AstraZeneca
AstraZeneca

Sevilla, Spain and 182 other locations

This study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People ca...

Enrolling
Metastatic Gastric Adenocarcinoma
Esophageal Adenocarcinoma
Drug: Trastuzumab
Drug: Capecitabine

Phase 1, Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Sevilla, Spain and 46 other locations

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: folinic acid
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Sevilla, Spain and 219 other locations

in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have received prior neoadjuva...

Enrolling
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer Metastatic
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Sevilla, Spain and 91 other locations

a dose expansion phase to confirm the dose and combination with bevacizumab. Approximately 500 adult participants with NSCLC, gastroesophageal adenocarcinoma...

Active, not recruiting
Gastroesophageal Adenocarcinoma
Advanced Solid Tumors
Drug: ABBV-400
Drug: Trifluridine/Tipiracil

Phase 1

AbbVie
AbbVie

Sevilla, Sevilla, Spain and 84 other locations

This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also measures a number...

Active, not recruiting
Lung Adenocarcinoma Stage IIIB/IV
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
Drug: Tepotinib

Phase 2

Merck KGaA (EMD Serono)
Merck KGaA (EMD Serono)

Sevilla, Spain and 176 other locations

T-DXd (Arm A) compared to trastuzumab, chemotherapy, and pembrolizumab (Arm B) in HER2-positive locally advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Adenocarcinoma
HER2-positive Gastric Cancer
Drug: Capecitabine
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Sevilla, Spain and 204 other locations

The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...

Active, not recruiting
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Other: Placebo
Drug: Nivolumab

Phase 3

Amgen
Amgen

Sevilla, Andalucía, Spain and 348 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems